Adial Pharmaceuticals Inc (ADIL)

$0.33 -0.03 (-7.14%)
Market Cap 2.77M
Revenue (ttm) 0.00
Net Income (ttm) -13.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 911,500
Avg Vol 1,099,308
Day's Range N/A - N/A
Shares Out 7.90M
Stochastic %K 1%
Beta 1.18
Analysts Strong Sell
Price Target $5.00

Company Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and i...

Industry: Biotechnology
Sector: Healthcare
Phone: (804) 487-8196
Address:
4870 Sadler Road, Suite 300, Glen Allen, United States
PMdungbeetle
PMdungbeetle Jun. 17 at 3:46 AM
$ADIL another one of my winner picks! I’m full of them! $MLSS $SKYX $WRAP $CRNT
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 16 at 11:43 PM
$ADIL
0 · Reply
Heywood_Jablomi
Heywood_Jablomi Jun. 16 at 5:26 PM
$ADIL in (again, been a while)
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 16 at 4:35 PM
$ADIL told u shorting u
0 · Reply
KpoloGayee
KpoloGayee Jun. 16 at 2:57 PM
$ADIL I have decided to save some funds and buy cheap whenever they put out PR. Seems like PR drops the price every time they’re published.
0 · Reply
CallMeVon
CallMeVon Jun. 16 at 2:57 PM
$ADIL taking this for a swing, new ceo is working on an upcoming merger🤔.
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:07 PM
$ADIL Adial Pharmaceuticals Submits The Required Briefing Package To the FDA For The Upcoming End Of Phase 2 Meeting BENZINGA 7:07 AM ET 6/16/2025
0 · Reply
dogood
dogood Jun. 16 at 12:07 PM
$ADIL great news but see how this stock with criminal offerings
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:01 PM
$ADIL End of Phase 2 Meeting has been Rescheduled for July 29 th Meeting to Discuss Upcoming Clinical Development Plan and Protocol Designs Strategic Partnership Discussions Expected to Accelerate Following a Positive FDA Meeting
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:00 PM
$ADIL Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting GLOBENEWSWIRE 7:00 AM ET 6/16/2025
0 · Reply
Latest News on ADIL
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 8:30 AM EDT - 4 weeks ago

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

May 13, 2025, 8:30 AM EDT - 4 weeks ago

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

May 2, 2025, 11:48 AM EDT - 6 weeks ago

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

May 1, 2025, 8:30 AM EDT - 6 weeks ago

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

Mar 4, 2025, 8:30 AM EST - 3 months ago

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Feb 25, 2025, 9:00 AM EST - 3 months ago

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Feb 19, 2025, 9:00 AM EST - 4 months ago

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Feb 12, 2025, 9:00 AM EST - 4 months ago

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Jan 29, 2025, 9:00 AM EST - 4 months ago

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

Dec 3, 2024, 8:30 AM EST - 6 months ago

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

Nov 5, 2024, 8:30 AM EST - 7 months ago

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Sep 19, 2024, 8:30 AM EDT - 9 months ago

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 9:00 AM EDT - 10 months ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14, 2024, 8:30 AM EDT - 10 months ago

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Aug 7, 2024, 9:00 AM EDT - 11 months ago

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

Jul 31, 2024, 8:30 AM EDT - 11 months ago

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Jul 23, 2024, 8:30 AM EDT - 11 months ago

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th

May 29, 2024, 8:30 AM EDT - 1 year ago

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

May 15, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

Apr 22, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

Adial Pharmaceuticals posts promising update on alcohol disorder drug

Apr 10, 2024, 2:15 PM EDT - 1 year ago

Adial Pharmaceuticals posts promising update on alcohol disorder drug

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Apr 2, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Mar 1, 2024, 7:00 PM EST - 1 year ago

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

Feb 28, 2024, 9:30 AM EST - 1 year ago

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

Feb 15, 2024, 9:00 AM EST - 1 year ago

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

Feb 13, 2024, 9:15 AM EST - 1 year ago

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Jan 18, 2024, 8:30 AM EST - 1 year ago

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate

Dec 20, 2023, 9:00 AM EST - 1 year ago

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

Nov 29, 2023, 4:05 PM EST - 1 year ago

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 14, 2023, 5:02 PM EST - 1 year ago

Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Oct 31, 2023, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

Oct 25, 2023, 8:00 AM EDT - 1 year ago

Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 24, 2023, 4:30 PM EDT - 1 year ago

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 20, 2023, 8:00 AM EDT - 1 year ago

Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

Oct 19, 2023, 12:00 PM EDT - 1 year ago

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence

Oct 19, 2023, 10:30 AM EDT - 1 year ago

Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence

Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

Oct 18, 2023, 8:00 AM EDT - 1 year ago

Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Sep 28, 2023, 7:00 AM EDT - 1 year ago

Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 5, 2023, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism

Aug 28, 2023, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Aug 23, 2023, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 21, 2023, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement and Reduce the Public Float

Aug 4, 2023, 8:30 AM EDT - 2 years ago

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement and Reduce the Public Float

Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings

Jul 11, 2023, 8:30 AM EDT - 2 years ago

Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings

Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th

Jun 1, 2023, 9:00 AM EDT - 2 years ago

Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th

Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

May 12, 2023, 8:30 AM EDT - 2 years ago

Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate's Assets and Business

May 10, 2023, 8:30 AM EDT - 2 years ago

Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate's Assets and Business

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update

Mar 30, 2023, 4:05 PM EDT - 2 years ago

Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update

PMdungbeetle
PMdungbeetle Jun. 17 at 3:46 AM
$ADIL another one of my winner picks! I’m full of them! $MLSS $SKYX $WRAP $CRNT
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 16 at 11:43 PM
$ADIL
0 · Reply
Heywood_Jablomi
Heywood_Jablomi Jun. 16 at 5:26 PM
$ADIL in (again, been a while)
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 16 at 4:35 PM
$ADIL told u shorting u
0 · Reply
KpoloGayee
KpoloGayee Jun. 16 at 2:57 PM
$ADIL I have decided to save some funds and buy cheap whenever they put out PR. Seems like PR drops the price every time they’re published.
0 · Reply
CallMeVon
CallMeVon Jun. 16 at 2:57 PM
$ADIL taking this for a swing, new ceo is working on an upcoming merger🤔.
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:07 PM
$ADIL Adial Pharmaceuticals Submits The Required Briefing Package To the FDA For The Upcoming End Of Phase 2 Meeting BENZINGA 7:07 AM ET 6/16/2025
0 · Reply
dogood
dogood Jun. 16 at 12:07 PM
$ADIL great news but see how this stock with criminal offerings
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:01 PM
$ADIL End of Phase 2 Meeting has been Rescheduled for July 29 th Meeting to Discuss Upcoming Clinical Development Plan and Protocol Designs Strategic Partnership Discussions Expected to Accelerate Following a Positive FDA Meeting
0 · Reply
MrTicker
MrTicker Jun. 16 at 12:00 PM
$ADIL Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting GLOBENEWSWIRE 7:00 AM ET 6/16/2025
0 · Reply
StayPresent
StayPresent Jun. 14 at 1:07 AM
$ADIL Claiborne and Goodman are true scu mbags. Diluting to pay their bills for a product that is recycled siht. RS and a quick P&D are our last hope for this pos.
0 · Reply
Muggy
Muggy Jun. 13 at 10:13 PM
$ADIL well, i tried. Pumped 15k into it at the ask after close and got nothing to show for it. Meeew. See ya on the next one
1 · Reply
Muggy
Muggy Jun. 13 at 5:55 PM
$ADIL order flow distribution out of wack. algos, please correct course
0 · Reply
dogood
dogood Jun. 13 at 4:24 PM
$ADIL wrong investment
0 · Reply
PRODUCTOF90S
PRODUCTOF90S Jun. 13 at 4:13 PM
$ADIL
0 · Reply
sonofoj
sonofoj Jun. 13 at 2:19 PM
$ADIL wow good news and then drop through bb and dropping down even more? Have never seen such thing Amazing ceo and management team should be bombarded and killed rather than iran people
0 · Reply
dogood
dogood Jun. 13 at 1:59 PM
$ADIL when You trust the science, look badly how they treat the company
0 · Reply
dogood
dogood Jun. 13 at 1:57 PM
$ADIL truely this is beaten badly
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 13 at 11:21 AM
$ADIL u may help me with some headache i have with another stock
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 13 at 11:20 AM
$ADIL was going to take u sub 0.20 but maybe ill be generous not as low let us see !
0 · Reply
Love_To_Learn
Love_To_Learn Jun. 12 at 5:52 PM
$ADIL shorting still accordingly
0 · Reply
makedatbread88
makedatbread88 Jun. 12 at 2:40 PM
$ADIL is this oversold territory now hmm 🤔
0 · Reply